A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder Academic Article uri icon

Overview

MeSH Major

  • Ambulatory Care
  • Antimanic Agents
  • Bipolar Disorder
  • Lithium Carbonate
  • Valproic Acid

abstract

  • The treatments did not differ significantly on time to recurrence of any mood episode during maintenance therapy. Patients treated with divalproex had better outcomes than those treated with placebo or lithium on several secondary outcome measures.

publication date

  • January 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/archpsyc.57.5.481

PubMed ID

  • 10807488

Additional Document Info

start page

  • 481

end page

  • 9

volume

  • 57

number

  • 5